Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Al-Aqar Healthcare REITXKLS:5116 -0.86%60 EV-to-EBITDA is 18.84 as of Aug. 09, 2026, which is 7% above its 10-year median of 17.61. GuruFocus rates XKLS:5116 with a GF Score™ of 60/100 and a GF Value™ of RM1.28 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 675 REITs companies, Al-Aqar Healthcare REIT ranks worse than 66.37% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Al-Aqar Healthcare REIT's enterprise value is RM1,878.9 Mil.
Al-Aqar Healthcare REIT's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was RM99.7 Mil. Therefore, Al-Aqar Healthcare REIT's EV-to-EBITDA for today is 18.84.
The historical rank and industry rank for Al-Aqar Healthcare REIT's EV-to-EBITDA or its related term are showing as below:
XKLS:5116'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.43 Med: 17.61 Max: 35.37
Current: 18.84
During the past 13 years, the highest EV-to-EBITDA of Al-Aqar Healthcare REIT was 35.37. The lowest was 12.43. And the median was 17.61.
XKLS:5116's EV-to-EBITDA is ranked worse than 66.37% of 675
companies
in the REITs industry
Industry Median: 15.47
vs XKLS:5116: 18.84
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Al-Aqar Healthcare REIT's PE Ratio (TTM) for today is calculated as:
Al-Aqar Healthcare REIT's share price for today is RM1.15.
Al-Aqar Healthcare REIT's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.068.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:5116 vs WELL, VTR, OHI: EV-to-EBITDA Comparison
For the REIT - Healthcare Facilities subindustry, Al-Aqar Healthcare REIT's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Al-Aqar Healthcare REIT EV-to-EBITDA vs REITs Industry
For the REITs industry and Real Estate sector, Al-Aqar Healthcare REIT's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Al-Aqar Healthcare REIT's EV-to-EBITDA falls into.
Al-Aqar Healthcare REIT's current Enterprise Value is RM1,878.9 Mil.
Al-Aqar Healthcare REIT's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM99.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Al-Aqar Healthcare REIT (XKLS:5116) has a EV-to-EBITDA of 18.84 as of Aug. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Al-Aqar Healthcare REIT. This is near median its historical median of 17.61. Over the past decade, Al-Aqar Healthcare REIT's EV-to-EBITDA has ranged from 12.43 to 35.37. According to the industry distribution chart, Al-Aqar Healthcare REIT ranks #448 out of 675 companies in the REITs industry, placing it in the top 66.4%.
Is Al-Aqar Healthcare REIT's EV-to-EBITDA too high?
Al-Aqar Healthcare REIT's current EV-to-EBITDA of 18.84 is near median its 10-year median of 17.61. Over the past 10 years, this metric has ranged from a low of 12.43 to a high of 35.37. The REITs industry median EV-to-EBITDA is 15.47. Al-Aqar Healthcare REIT's value of 18.84 is 21.8% above this industry median. Based on the distribution chart, Al-Aqar Healthcare REIT ranks #448 out of 675 companies in the REITs industry, which is below the industry midpoint. Overall, Al-Aqar Healthcare REIT has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al-Aqar Healthcare REIT's EV-to-EBITDA compare to WELL and VTR?
According to the REITs industry distribution chart, Al-Aqar Healthcare REIT ranks #448 out of 675 companies for EV-to-EBITDA. This places Al-Aqar Healthcare REIT in the lower half of its industry. The industry median EV-to-EBITDA is 15.47. Al-Aqar Healthcare REIT's value of 18.84 is 21.8% above this benchmark. Historically, Al-Aqar Healthcare REIT's own EV-to-EBITDA has ranged from 12.43 to 35.37 over the past decade. While the company's 10-year median is 17.61 vs. the industry median of 15.47, Al-Aqar Healthcare REIT has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a REITs company?
The median EV-to-EBITDA among REITs companies is 15.47, based on 675 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Al-Aqar Healthcare REIT's current EV-to-EBITDA of 18.84 is 21.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Al-Aqar Healthcare REIT. For the REITs industry, the median EV-to-EBITDA is 15.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Al-Aqar Healthcare REIT's current EV-to-EBITDA is 18.84, which is near median its own 10-year median of 17.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al-Aqar Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, Al-Aqar Healthcare REIT (XKLS:5116) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.28, compared to a current price of RM1.15 — trading 10.2% below its estimated fair value. The current EV-to-EBITDA is 18.84, which is near median its 10-year median of 17.61 and 21.8% above the REITs industry median of 15.47. Al-Aqar Healthcare REIT's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Al-Aqar Healthcare REIT (XKLS:5116), the current EV-to-EBITDA is 18.84 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Al-Aqar Healthcare REIT (XKLS:5116) Overvalued in 2026?
Based on GuruFocus' analysis, Al-Aqar Healthcare REIT stock appears to be undervalued.
The current stock price of RM1.15 is trading 10.2% below its estimated GF Value™ of RM1.28.
GuruFocus considers Al-Aqar Healthcare REIT to be Modestly Undervalued.
Key valuation signals for XKLS:5116:
EV-to-EBITDA: 18.84 (near median its 10-year median of 17.61)
GF Value™: RM1.28 vs. price of RM1.15 (10.2% below fair value)
Industry Position: 21.8% above the REITs median (#448 of 675)
No single metric tells the full story. See the XKLS:5116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Al-Aqar Healthcare REIT is engaged in investing in Syariah-compliant properties with the primary objective of providing unitholders with distribution and potential for the sustainable long-term growth of such distribution and capital appreciation. The company operates in Malaysia and Australia. The Malaysian geographic segment generates the maximum revenue for the company.
60GF Score
Get the complete analysis for XKLS:5116
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5116 has been successfully added to your 
